HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Topical application of imiquimod for the treatment of high-risk facial basal cell carcinoma in Gorlin syndrome.

AuthorsP Vereecken, E Monsieur, M Petein, M Heenen
JournalThe Journal of dermatological treatment (J Dermatolog Treat) Vol. 15 Issue 2 Pg. 120-1 (Apr 2004) ISSN: 0954-6634 [Print] England
PMID15204165 (Publication Type: Case Reports, Letter)
Chemical References
  • Aminoquinolines
  • Antineoplastic Agents
  • Imiquimod
Topics
  • Administration, Cutaneous
  • Adult
  • Aminoquinolines (administration & dosage)
  • Antineoplastic Agents (administration & dosage)
  • Basal Cell Nevus Syndrome
  • Carcinoma, Basal Cell (drug therapy, pathology)
  • Face
  • Humans
  • Imiquimod
  • Male
  • Skin Neoplasms (drug therapy, pathology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: